
Marrone Bio Innovations Investor Relations Material
Latest events

Q1 2022
Marrone Bio Innovations
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Marrone Bio Innovations Inc
Access all reports
Marrone Bio Innovations, Inc. develops beneficial bacillus products for crop yield, quality, and performance. The company's products are manufactured from naturally occurring soil bacteria that have been used as microbial pesticides to control pests such as nematodes, insects, and mites. Its products include Regalia, Great Lakes BioSystems' proprietary plant-based bacillus formula for enhancing plant growth and controlling fungal disease; Grandevo, a biopesticide containing three different strains of beneficial bacilli for controlling insect pests and diseases; and Majestene, an insecticide containing various biopesticides to suppress nematode populations.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
MBII
Country
🇺🇸 United States